To determine if the donor-specific response we observed in the melanoma co-culture after nNOS inhibitor treatment was associated with preexisting immunological states in the donor samples, we used a more detailed T cell immunophenotyping panel (Supplementary Figure S6) to profile the T cell populations in the donor samples. This evidence concerns the gene NOS1 and melanoma.